Definium Therapeutics
DFTX
174 hedge funds and large institutions have $105M invested in Definium Therapeutics in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 17 closing their positions.
129% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 17
59% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 34
18% more call options, than puts
Call options by funds: $7.82M | Put options by funds: $6.62M
12% more funds holding
Funds holding: 155 → 174 (+19)
0.13% more ownership
Funds ownership: 0.74% → 0.87% (+0.13%)
20% less capital invested
Capital invested by funds: $130M → $105M (-$25.5M)
Top Buyers
| 1 |
Northern Trust
Chicago,
Illinois
|
+$6.83M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.34M |
| 3 |
BlackRock
New York
|
+$2.87M |
| 4 |
BB
Busey Bank
Urbana,
Illinois
|
+$2.35M |
| 5 |
Goldman Sachs
New York
|
+$2.14M |
Top Sellers
| 1 |
Jane Street
New York
|
-$1.65M |
| 2 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$737K |
| 3 |
UBS AM
Chicago,
Illinois
|
-$567K |
| 4 |
VF
Virtu Financial
New York
|
-$564K |
| 5 |
JP Morgan Chase
New York
|
-$532K |
DFTX Hedge Fund Activity: Q3 2021 in Review
174 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2021, worth a combined $105M — down 20% from $130M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new DFTX positions and 17 closed out — a net gain of 22 holders — while 54 added to existing stakes and 34 trimmed.
The largest buyer was Northern Trust, adding an estimated $6.83M. The largest seller was Jane Street, cutting an estimated $1.65M.
- 174 institutional investors held Definium Therapeutics (DFTX) as of Q3 2021, up from 155 in Q2 2021.
- Funds reported $105M of Definium Therapeutics stock for Q3 2021, down 20% quarter-over-quarter.
- 39 funds opened new Definium Therapeutics positions in Q3 2021 and 17 closed out, a net change of +22 holders.
- The largest Definium Therapeutics buyer in Q3 2021 was Northern Trust, an estimated $6.83M added.
- The largest Definium Therapeutics seller in Q3 2021 was Jane Street, an estimated $1.65M sold.
Based on aggregated 13F filings for Q3 2021.